{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:36:38Z","timestamp":1782099398354,"version":"3.54.5"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Tuberculosis screening in psoriasis patients is complex due to the immunological alterations associated with psoriasis, the presence of comorbidities, and the effect of immunosuppressive treatment. However, it is not established whether the results of screening tests are affected by these factors in psoriasis patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>To determine whether there is a change in the results of the tuberculin skin test (TST) or the interferon-gamma release assay (IGRA) in psoriasis patients living in tuberculosis (TB)-endemic area after 12 weeks of methotrexate (MTX) treatment and to investigate the association of the test results with clinical and inflammatory markers.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Forty-five patients were selected for a prospective single-arm self-controlled study and followed for at least 18 months. The TST, IGRA, Psoriasis Area and Severity Index (PASI), and inflammatory factors (erythrocyte sedimentation rate (ESR), C-reactive protein, interferon-gamma (IFN-\u03b3), and tumor necrosis factor-alpha levels), were determined before and after 12 weeks of oral 15 mg per week MTX administration and compared. The associations between the IGRA and TST results were verified before and after treatment according to inflammatory factors and clinical characteristics (age, blood glucose, weight, body mass index, disease duration, and PASI).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>We collected data on 25 patients who completed the full course of therapy and the follow-up. None of the patients developed TB. TST positivity was significantly elevated at week 12 (25% baseline vs 44% at week 12, P &lt; 0.037). Three IGRAs followed the TST conversions. There was no difference between TST and IGRA pre- or posttreatment. Serum IFN-\u03b3 increased significantly in week 12 (15.95 pg\/ml baseline vs 18.82 pg\/ml at week 12, P &lt; 0.005) and tended to be higher among TST-positive patients (P = 0.072). The baseline IGRA was associated with a higher ESR (P = 0.038). None of the test results were associated with clinical characteristics.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In addition to the classic booster effect, TST conversions in patients using MTX can occur due to an increase in IFN-\u03b3. However, it is not possible to exclude true TST conversions. Therefore, other diagnostic methods, like IGRA or chest tomography, should be used when the TST has intermediate results.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0242098","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T19:29:15Z","timestamp":1607023755000},"page":"e0242098","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1445-587X","authenticated-orcid":true,"given":"Vanessa Luc\u00edlia Silveira","family":"de Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Cristina Fulco","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edlian Maria Lapa","family":"Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria da Concei\u00e7\u00e3o","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vald\u00eania Maria Oliveira de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginaldo Gon\u00e7alvez de","family":"Lima Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edbia Cristina Rocha Vilela","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"pone.0242098.ref001","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"IM Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"pone.0242098.ref002","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00403-014-1493-3","article-title":"Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17\/Th2 imbalance of psoriasis","volume":"306","author":"A Campanati","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"pone.0242098.ref003","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2018.06.057","article-title":"Psoriasis: which therapy for which patient: psoriasis comorbidities and preferred systemic agents","volume":"80","author":"SB Kaushik","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"pone.0242098.ref004","doi-asserted-by":"crossref","first-page":"118623","DOI":"10.1016\/j.ijpharm.2019.118623","article-title":"Development, characterization and evaluation of topical methotrexate-entrapped deformable liposome on imiquimod-induced psoriasis in a mouse model","volume":"569","author":"M Bahramizadeh","year":"2019","journal-title":"Int J Pharm"},{"key":"pone.0242098.ref005","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.intimp.2019.05.042","article-title":"Efficacy and safety of etanercept combined plus methotrexate and comparison of expression of pro-inflammatory factors expression for the treatment of moderate-to-severe plaque psoriasis","volume":"73","author":"Q Yu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"pone.0242098.ref006","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ad.2015.10.005","article-title":"Methotrexate in moderate to severe psoriasis: review of the literature and expert recommendations","volume":"107","author":"JM Carrascosa","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"pone.0242098.ref007","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40257-019-00432-y","article-title":"Active tuberculosis in patients with psoriasis receiving biologic therapy: a systematic review","volume":"20","author":"I Snast","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"pone.0242098.ref008","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/cid\/cix852","article-title":"Association of obesity, diabetes, and risk of tuberculosis: two population-based cohorts","volume":"66","author":"HH Lin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"pone.0242098.ref009","first-page":"207","article-title":"Screening for latent tuberculosis in the patient with moderate to severe psoriasis who is a candidate for systemic and\/or biologic therapy","volume":"107","author":"A Mart\u00ednez-L\u00f3pez","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"pone.0242098.ref010","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2340\/00015555-1151","article-title":"Evaluation of an IFN-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting","volume":"91","author":"E de Andrade Lima","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"pone.0242098.ref011","doi-asserted-by":"crossref","first-page":"381929","DOI":"10.1155\/2012\/381929","article-title":"Immunosuppression adversely affects TST but Not IGRAs in patients with psoriasis or inflammatory musculoskeletal diseases","volume":"2012","author":"E Tavast","year":"2012","journal-title":"Int J Rheumatol"},{"key":"pone.0242098.ref012","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/bjd.12176","article-title":"Evaluating the use of the interferon-\u03b3 response to Mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-\u03b1 therapy: a prospective head-to-head cross-sectional study","volume":"168","author":"CL Martyn-Simmons","year":"2013","journal-title":"Br J Dermatol"},{"key":"pone.0242098.ref013","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/bjd.12544","article-title":"Interferon-\u03b3 release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis","volume":"169","author":"I Sauzullo","year":"2013","journal-title":"Br J Dermatol"},{"key":"pone.0242098.ref014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10238-012-0192-7","article-title":"Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases","volume":"13","author":"JM Ramos","year":"2013","journal-title":"Clin Exp Med"},{"key":"pone.0242098.ref015","doi-asserted-by":"crossref","first-page":"e0189202","DOI":"10.1371\/journal.pone.0189202","article-title":"Immune-mediated inflammatory diseases differently affect IGRAs' accuracy for latent tuberculosis infection diagnosis in clinical practice","volume":"12","author":"I Latorre","year":"2017","journal-title":"PLoS One"},{"key":"pone.0242098.ref016","doi-asserted-by":"crossref","first-page":"1701630","DOI":"10.1183\/13993003.01630-2017","article-title":"Proof of concept that most borderline quantiferon results are true antigen-specific responses","volume":"50","author":"JW Uzorka","year":"2017","journal-title":"Eur Respir J"},{"key":"pone.0242098.ref017","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","article-title":"Optimization and interpretation of serial QuantiFERON testing to measure acquisition of mycobacterium tuberculosis infection","volume":"196","author":"E Nemes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0242098.ref018","doi-asserted-by":"crossref","first-page":"e0184178","DOI":"10.1371\/journal.pone.0184178","article-title":"Serial QuantiFERON-TB gold testing in patients with psoriasis treated with ustekinumab","volume":"12","author":"CY Hsiao","year":"2017","journal-title":"PLoS One"},{"key":"pone.0242098.ref019","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13555-013-0020-3","article-title":"Dynamic QuantiFERON response in psoriasis patients taking long-term biologic therapy","volume":"3","author":"L Drago","year":"2013","journal-title":"Dermatol Ther (Heidelb)"},{"key":"pone.0242098.ref020","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1513\/AnnalsATS.201310-378OC","article-title":"IFN-\u03b3 release assay conversions and reversions. Challenges with serial testing in U.S. health care workers","volume":"11","author":"M Joshi","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"pone.0242098.ref021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cca.2013.12.038","article-title":"Significance of interferon-gamma response to mitogen in serial QuantiFERON-TB gold in-tube assay of routine laboratory practice","volume":"430","author":"KS Woo","year":"2014","journal-title":"Clin Chim Acta"},{"key":"pone.0242098.ref022","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/thoraxjnl-2015-207687","article-title":"The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection","volume":"71","author":"JA Seddon","year":"2016","journal-title":"Thorax"},{"key":"pone.0242098.ref023","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.chest.2017.01.001","article-title":"The long-term effect of Bacille Calmette-Gu\u00e9rin vaccination on tuberculin skin testing: a 55-year follow-up study","volume":"152","author":"JD Mancuso","year":"2017","journal-title":"Chest"},{"key":"pone.0242098.ref024","doi-asserted-by":"crossref","first-page":"e20173918","DOI":"10.1542\/peds.2017-3918","article-title":"Interferon-\u03b3 release assay performance for tuberculosis in childhood","volume":"141","author":"AW Kay","year":"2018","journal-title":"Pediatrics"},{"key":"pone.0242098.ref025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-319-33919-1_6","volume-title":"Dermatology in public health environments a comprehensive textbook","author":"J Santos","year":"2018"},{"key":"pone.0242098.ref026","unstructured":"Menzies D. Use of the Tuberculin Skin Test for Diagnosis of Latent Tuberculosis Infection (Tuberculosis Screening) in Adults. In: Baron, EL editor. UpToDate. Waltham, MA: UpToDate; 2020 [cited 05\/18\/20]. Available from: https:\/\/www.uptodate.com"},{"key":"pone.0242098.ref027","doi-asserted-by":"crossref","first-page":"e9681","DOI":"10.1097\/MD.0000000000009681","article-title":"Household tuberculosis contact investigation in a tuberculosis-prevalent country: are the tuberculin skin test and interferon-gamma release assay enough in elderly contacts?","volume":"97","author":"JS Eom","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"pone.0242098.ref028","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.rmed.2015.12.002","article-title":"Comparison of latent tuberculosis infection rate between contacts with active tuberculosis and non-contacts","volume":"111","author":"JW Yoo","year":"2016","journal-title":"Respir Med"},{"key":"pone.0242098.ref029","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/ijd.12973","article-title":"Association of clinical properties and compatibility of the QuantiFERON-TB gold in-tube test with the tuberculin skin test in patients with psoriasis","volume":"55","author":"AK To\u011fral","year":"2016","journal-title":"Int J Dermatol"},{"key":"pone.0242098.ref030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000222431","article-title":"Tuberculin skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis","volume":"219","author":"G Tsiouri","year":"2009","journal-title":"Dermatology"},{"key":"pone.0242098.ref031","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2340\/00015555-1106","article-title":"Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease","volume":"91","author":"ID Bassukas","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"pone.0242098.ref032","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1186\/s12879-018-3508-8","article-title":"Interferon-\u03b3 release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study","volume":"18","author":"GB Klautau","year":"2018","journal-title":"BMC Infect Dis"},{"key":"pone.0242098.ref033","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00296-017-3852-9","article-title":"IGRA testing in patients with immune-mediated inflammatory diseases: which factors influence the results?","volume":"38","author":"J Gonz\u00e1lez-Moreno","year":"2018","journal-title":"Rheumatol Int"},{"key":"pone.0242098.ref034","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jinf.2014.07.026","article-title":"Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis","volume":"69","author":"I Latorre","year":"2014","journal-title":"J Infect"},{"key":"pone.0242098.ref035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.semarthrit.2018.03.018","article-title":"High rates of tuberculin skin test positivity due to methotrexate therapy: false positive results?","volume":"48","author":"M Arias-Guill\u00e9n","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"pone.0242098.ref036","doi-asserted-by":"crossref","first-page":"e107299","DOI":"10.1371\/journal.pone.0107299","article-title":"Methotrexate-related response on human peripheral blood mononuclear cells may be modulated by the Ala16Val-SOD2 gene polymorphism","volume":"9","author":"F Barbisan","year":"2014","journal-title":"PLoS One"},{"key":"pone.0242098.ref037","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/08923973.2014.884135","article-title":"Protective effect of peroxisome proliferator activator receptor (PPAR)-\u03b1 and -\u03b3 ligands against methotrexate-induced nephrotoxicity","volume":"36","author":"M Ibrahim","year":"2014","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"pone.0242098.ref038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01480545.2020.1719132","article-title":"Naringenin: a potential natural remedy against methotrexate-induced hepatotoxicity in rats","author":"A Malayeri","year":"2020","journal-title":"Drug Chem Toxicol"},{"key":"pone.0242098.ref039","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/ijd.12628","article-title":"The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents","volume":"54","author":"T Ergun","year":"2015","journal-title":"Int J Dermatol"},{"key":"pone.0242098.ref040","first-page":"823","article-title":"Estimation of the prevalence of latent tuberculosis infection in patients with moderate to severe plaque psoriasis in Spain: the latent study","volume":"106","author":"M Ribera","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"pone.0242098.ref041","doi-asserted-by":"crossref","first-page":"e96564","DOI":"10.1371\/journal.pone.0096564","article-title":"Discordance of tuberculin skin test and interferon-gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil","volume":"9","author":"R Ribeiro-Rodrigues","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"pone.0242098.ref042","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/1751-2980.12437","article-title":"Tuberculosis screening using IGRA and chest computed tomography in patients with inflammatory bowel disease: A retrospective study","volume":"18","author":"DJ Song","year":"2017","journal-title":"J Dig Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0242098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T19:29:46Z","timestamp":1607023786000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0242098"}},"subtitle":[],"editor":[{"given":"Remco PH","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0242098","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]}}}